Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXGY7A
|
||||
Drug Name |
N-(4-bromophenethyl)-N-((4-(4-cyanobenzyl)-4H-1,2,4-triazol-3-yl)methyl)-4-methoxyquinoline-2-carboxamide
|
||||
Synonyms |
CHEMBL426837
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C30H25BrN6O2
|
||||
Canonical SMILES |
COc1cc(nc2ccccc12)C(=O)N(CCc3ccc(Br)cc3)Cc4nncn4Cc5ccc(cc5)C#N
|
||||
InChI |
InChI=1S/C30H25BrN6O2/c1-39-28-16-27(34-26-5-3-2-4-25(26)28)30(38)36(15-14-21-10-12-24(31)13-11-21)19-29-35-33-20-37(29)18-23-8-6-22(17-32)7-9-23/h2-13,16,20H,14-15,18-19H2,1H3
|
||||
InChIKey |
ADZRJKLOXYZNBT-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.